Annual Total Expenses
$59.16 M
-$10.44 M-15.00%
December 31, 2023
Summary
- As of March 6, 2025, CASI annual total expenses is $59.16 million, with the most recent change of -$10.44 million (-15.00%) on December 31, 2023.
- During the last 3 years, CASI annual total expenses has risen by +$10.71 million (+22.09%).
- CASI annual total expenses is now -15.00% below its all-time high of $69.60 million, reached on December 31, 2022.
Performance
CASI Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$15.88 M
+$2.35 M+17.33%
September 1, 2024
Summary
- As of March 6, 2025, CASI quarterly total expenses is $15.88 million, with the most recent change of +$2.35 million (+17.33%) on September 1, 2024.
- Over the past year, CASI quarterly total expenses has increased by +$4.24 million (+36.42%).
- CASI quarterly total expenses is now -34.64% below its all-time high of $24.29 million, reached on December 31, 2001.
Performance
CASI Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
CASI Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.0% | +36.4% |
| 3 y3 years | +22.1% | +36.4% |
| 5 y5 years | +123.2% | +36.4% |
CASI Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.0% | at low | -22.4% | +36.4% |
| 5 y | 5-year | -15.0% | +35.3% | -22.4% | +58.5% |
| alltime | all time | -15.0% | +1043.5% | -34.6% | +1611.4% |
CASI Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.88 M(+17.3%) |
| Jun 2024 | - | $13.53 M(+7.2%) |
| Mar 2024 | - | $12.63 M(+8.5%) |
| Dec 2023 | $59.16 M(-15.0%) | $11.64 M(-17.4%) |
| Sep 2023 | - | $14.09 M(-26.3%) |
| Jun 2023 | - | $19.12 M(+22.4%) |
| Mar 2023 | - | $15.62 M(-23.3%) |
| Dec 2022 | $69.60 M(+6.4%) | $20.36 M(+22.9%) |
| Sep 2022 | - | $16.57 M(+1.5%) |
| Jun 2022 | - | $16.32 M(-0.2%) |
| Mar 2022 | - | $16.35 M(-20.1%) |
| Dec 2021 | $65.39 M(+34.9%) | $20.46 M(+36.4%) |
| Sep 2021 | - | $15.00 M(+6.5%) |
| Jun 2021 | - | $14.09 M(-11.0%) |
| Mar 2021 | - | $15.83 M(+6.6%) |
| Dec 2020 | $48.45 M(+10.8%) | $14.85 M(+23.3%) |
| Sep 2020 | - | $12.04 M(+20.1%) |
| Jun 2020 | - | $10.02 M(-13.2%) |
| Mar 2020 | - | $11.55 M(-4.2%) |
| Dec 2019 | $43.71 M(+64.9%) | $12.05 M(-10.3%) |
| Sep 2019 | - | $13.43 M(+34.8%) |
| Jun 2019 | - | $9.96 M(+20.3%) |
| Mar 2019 | - | $8.28 M(-8.2%) |
| Dec 2018 | $26.50 M(+146.5%) | $9.02 M(+3.6%) |
| Sep 2018 | - | $8.71 M(+50.9%) |
| Jun 2018 | - | $5.77 M(+92.4%) |
| Mar 2018 | - | $3.00 M(-40.5%) |
| Dec 2017 | $10.75 M(+14.1%) | $5.04 M(+215.7%) |
| Sep 2017 | - | $1.60 M(-34.0%) |
| Jun 2017 | - | $2.42 M(+42.8%) |
| Mar 2017 | - | $1.69 M(-36.5%) |
| Dec 2016 | $9.42 M(+30.8%) | $2.67 M(+57.8%) |
| Sep 2016 | - | $1.69 M(-48.4%) |
| Jun 2016 | - | $3.28 M(+83.7%) |
| Mar 2016 | - | $1.78 M(+4.7%) |
| Dec 2015 | $7.20 M(+10.3%) | $1.70 M(+5.4%) |
| Sep 2015 | - | $1.62 M(-22.4%) |
| Jun 2015 | - | $2.08 M(+16.0%) |
| Mar 2015 | - | $1.80 M(+11.2%) |
| Dec 2014 | $6.53 M(+13.8%) | $1.61 M(-12.6%) |
| Sep 2014 | - | $1.85 M(+14.3%) |
| Jun 2014 | - | $1.62 M(+11.4%) |
| Mar 2014 | - | $1.45 M(+10.9%) |
| Dec 2013 | $5.74 M(+11.0%) | $1.31 M(-9.3%) |
| Sep 2013 | - | $1.44 M(-22.1%) |
| Jun 2013 | - | $1.85 M(+63.0%) |
| Mar 2013 | - | $1.14 M(+10.3%) |
| Dec 2012 | $5.17 M(-20.5%) | $1.03 M(-13.3%) |
| Sep 2012 | - | $1.19 M(-8.5%) |
| Jun 2012 | - | $1.30 M(-21.7%) |
| Mar 2012 | - | $1.66 M(+78.7%) |
| Dec 2011 | $6.51 M(-20.9%) | $927.80 K(-26.4%) |
| Sep 2011 | - | $1.26 M(-24.5%) |
| Jun 2011 | - | $1.67 M(-37.0%) |
| Mar 2011 | - | $2.65 M(+3.3%) |
| Dec 2010 | $8.23 M | $2.57 M(+29.5%) |
| Sep 2010 | - | $1.98 M(+11.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | $1.78 M(-6.0%) |
| Mar 2010 | - | $1.90 M(-36.5%) |
| Dec 2009 | $12.01 M(-56.9%) | $2.98 M(-7.9%) |
| Sep 2009 | - | $3.24 M(+21.3%) |
| Jun 2009 | - | $2.67 M(-14.2%) |
| Mar 2009 | - | $3.11 M(-47.5%) |
| Dec 2008 | $27.83 M(-10.6%) | $5.93 M(-8.9%) |
| Sep 2008 | - | $6.51 M(-9.9%) |
| Jun 2008 | - | $7.22 M(-11.6%) |
| Mar 2008 | - | $8.17 M(+7.1%) |
| Dec 2007 | $31.13 M(+7.1%) | $7.63 M(+11.9%) |
| Sep 2007 | - | $6.82 M(-19.4%) |
| Jun 2007 | - | $8.45 M(+2.7%) |
| Mar 2007 | - | $8.23 M(-17.7%) |
| Dec 2006 | $29.06 M(+25.0%) | $9.99 M(+41.9%) |
| Sep 2006 | - | $7.04 M(+13.6%) |
| Jun 2006 | - | $6.20 M(+6.4%) |
| Mar 2006 | - | $5.83 M(-10.9%) |
| Dec 2005 | $23.25 M(+36.0%) | $6.54 M(+10.5%) |
| Sep 2005 | - | $5.92 M(+14.8%) |
| Jun 2005 | - | $5.15 M(-8.7%) |
| Mar 2005 | - | $5.64 M(+56.5%) |
| Dec 2004 | $17.09 M(-19.7%) | $3.60 M(-7.4%) |
| Sep 2004 | - | $3.89 M(-12.5%) |
| Jun 2004 | - | $4.45 M(-13.6%) |
| Mar 2004 | - | $5.15 M(-21.1%) |
| Dec 2003 | $21.28 M(-53.0%) | $6.52 M(+33.2%) |
| Sep 2003 | - | $4.90 M(-12.4%) |
| Jun 2003 | - | $5.59 M(+31.4%) |
| Mar 2003 | - | $4.26 M(-39.2%) |
| Dec 2002 | $45.24 M(-34.1%) | $7.00 M(-41.9%) |
| Sep 2002 | - | $12.04 M(+4.3%) |
| Jun 2002 | - | $11.55 M(-21.2%) |
| Mar 2002 | - | $14.65 M(-39.7%) |
| Dec 2001 | $68.67 M(+26.3%) | $24.29 M(+46.1%) |
| Sep 2001 | - | $16.63 M(+4.4%) |
| Jun 2001 | - | $15.93 M(+34.7%) |
| Mar 2001 | - | $11.82 M(-23.0%) |
| Dec 2000 | $54.39 M(+25.0%) | $15.35 M(+19.5%) |
| Sep 2000 | - | $12.84 M(-11.0%) |
| Jun 2000 | - | $14.43 M(+22.6%) |
| Mar 2000 | - | $11.77 M(-25.0%) |
| Dec 1999 | $43.50 M(+108.1%) | $15.70 M(+70.7%) |
| Sep 1999 | - | $9.20 M(-4.4%) |
| Jun 1999 | - | $9.62 M(+6.9%) |
| Mar 1999 | - | $9.00 M(+34.4%) |
| Dec 1998 | $20.90 M(+50.4%) | $6.70 M(+13.6%) |
| Sep 1998 | - | $5.90 M(+68.6%) |
| Jun 1998 | - | $3.50 M(-27.1%) |
| Mar 1998 | - | $4.80 M(+20.0%) |
| Dec 1997 | $13.90 M(+26.4%) | $4.00 M(+8.1%) |
| Sep 1997 | - | $3.70 M(+27.6%) |
| Jun 1997 | - | $2.90 M(-6.5%) |
| Mar 1997 | - | $3.10 M(-6.1%) |
| Dec 1996 | $11.00 M | $3.30 M(+6.5%) |
| Sep 1996 | - | $3.10 M(+82.4%) |
| Jun 1996 | - | $1.70 M(-39.3%) |
| Mar 1996 | - | $2.80 M |
FAQ
- What is CASI Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals annual total expenses year-on-year change?
- What is CASI Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals quarterly total expenses year-on-year change?
What is CASI Pharmaceuticals annual total expenses?
The current annual total expenses of CASI is $59.16 M
What is the all time high annual total expenses for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high annual total expenses is $69.60 M
What is CASI Pharmaceuticals annual total expenses year-on-year change?
Over the past year, CASI annual total expenses has changed by -$10.44 M (-15.00%)
What is CASI Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of CASI is $15.88 M
What is the all time high quarterly total expenses for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high quarterly total expenses is $24.29 M
What is CASI Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, CASI quarterly total expenses has changed by +$4.24 M (+36.42%)